7ZL4 image
Entry Detail
PDB ID:
7ZL4
EMDB ID:
Keywords:
Title:
Cryo-EM structure of archaic chaperone-usher Csu pilus of Acinetobacter baumannii
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-04-13
Release Date:
2022-08-03
Method Details:
Experimental Method:
Resolution:
3.45 Å
Aggregation State:
FILAMENT
Reconstruction Method:
HELICAL
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CsuA/B
Chain IDs:A, B, C, D
Chain Length:155
Number of Molecules:4
Biological Source:Acinetobacter baumannii
Ligand Molecules
Primary Citation
Archaic chaperone-usher pili self-secrete into superelastic zigzag springs.
Nature 609 335 340 (2022)
PMID: 35853476 DOI: 10.1038/s41586-022-05095-0

Abstact

Adhesive pili assembled through the chaperone-usher pathway are hair-like appendages that mediate host tissue colonization and biofilm formation of Gram-negative bacteria1-3. Archaic chaperone-usher pathway pili, the most diverse and widespread chaperone-usher pathway adhesins, are promising vaccine and drug targets owing to their prevalence in the most troublesome multidrug-resistant pathogens1,4,5. However, their architecture and assembly-secretion process remain unknown. Here, we present the cryo-electron microscopy structure of the prototypical archaic Csu pilus that mediates biofilm formation of Acinetobacter baumannii-a notorious multidrug-resistant nosocomial pathogen. In contrast to the thick helical tubes of the classical type 1 and P pili, archaic pili assemble into an ultrathin zigzag architecture secured by an elegant clinch mechanism. The molecular clinch provides the pilus with high mechanical stability as well as superelasticity, a property observed for the first time, to our knowledge, in biomolecules, while enabling a more economical and faster pilus production. Furthermore, we demonstrate that clinch formation at the cell surface drives pilus secretion through the outer membrane. These findings suggest that clinch-formation inhibitors might represent a new strategy to fight multidrug-resistant bacterial infections.

Legend

Protein

Chemical

Disease

Primary Citation of related structures